In-Depth Characterisation of Real-World Advanced Melanoma Patients Receiving Immunotherapies and/or Targeted Therapies: A Case Series

SIMPLE SUMMARY: Immunotherapies and targeted therapies have led to improved melanoma survival in clinical trial settings. While this is also true in real-world settings, it is much less studied. Clinical trials have strict inclusion criteria and, therefore, a relatively homogenous set of participant...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanjida, Saira, Betz-Stablein, Brigid, Atkinson, Victoria, Janda, Monika, Barsoum, Ramez, Edwards, Harrison Aljian, Chiu, Frank, Tran, My Co, Soyer, H Peter, Schaider, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179437/
https://www.ncbi.nlm.nih.gov/pubmed/35681781
http://dx.doi.org/10.3390/cancers14112801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179437/
https://www.ncbi.nlm.nih.gov/pubmed/35681781
http://dx.doi.org/10.3390/cancers14112801

Ejemplares similares